Here are relevant reports on : pet-training-market
-
Probiotic and Prebiotic Pet Foods Market - Global Forecast to 2029
The Probiotic and Prebiotic Market is estimated at USD XX billion in 2024 and is projected to reach USD XX billion by 2029, at a CAGR of XX% from 2024 to 2029. Key players operating in the food and beverage metal cans equipment market include Probi (Sweden), Royal Canin (France), Nestlé Purina PetCare(US), Mars Inc. CHR. Hansen (Denmark), Kinglike DSM N.V (Netherlands), Dow DuPont (US), Evonik Industries (Germany) . These players in this market are focusing on increasing their presence through expansion and collaboration. These companies have a strong presence in North America, Asia Pacific, and Europe.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Pet Food Flavors Market - Global Forecast to 2029
Pet Food Flavors Market
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Pet Food Palatants Market - Global Forecast to 2029
Pet Food Palatants Market
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Training Manikins Trends & Technology Market- 2019 By Types, Application & Geography
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Training Manikins Market - 2019 By Types, Application & Geography Upcoming Trends & Technology
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Grain-Free Pet Foods Market By Pet Types (Dogs, Cats, And Other Companion Pets), Product Type (Dry Pet Food, Wet Pet Food, Treat & Supplements), Distribution Channel (Modern Trade, Departmental Stores, Pet Specialty Stores, Online Retailers, And Other Channels), Ingredient Type (Meat-Based, Plant-Based And Alternative Protein Sources), And Region - Global Forecast to 2029
The global grain-free pet foods market growth is on a trajectory of significant expansion, with an estimated value projected to reach USD XX billion by 2029 from the 2024 valuation of USD XX billion, displaying a promising Compound Annual Growth Rate (CAGR) of XX%. The key players in this market include Blue Buffalo Company, Ltd. (US), Wellness Pet, LLC (US ), SCHELL & KAMPETER, INC. (US), Nulo (US), GoDaddy Operating Company, LLC. (US), Canidae (US), Nestlé S.A. (Switzerlands), Farmina Pet Foods (Italy), Mars, Incorporated (US), and Dr. Tim's Pet Food Company (US).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
AI in Military Training and Simulation Market by Technology (Machine Learning, Virtual Reality, Augmented Reality, Predictive Analytics), By Application (Combat Training, Flight Simulation, Tactical Training, CBRN Simulation, Other Applications), By End User (Armed Forces, Defense Contractors, Military Training Institutes, Other Sectors) and Region - Global Forecast to 2030
The major players in the global AI in Military Training and Simulation Market
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
European Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)), Application (Oncology, Thyroid, Cardiology), Procedures - Forecasts to 2020
Over the years, the European nuclear medicine/radiopharmaceuticals market has witnessed various advancements in radiopharmaceuticals. The European radiopharmaceuticals market is witnessing growth owing to an increasing number of radioisotope approvals for different clinical indications. Tc-99m and F-18 radioisotopes are estimated to contribute the highest to the European nuclear medicine diagnostic market in 2015, whereas Ra-223, I-131 and Y-90 ensured their leading position in the therapeutic market. The European nuclear medicine/radiopharmaceuticals market is expected to reach $1.62 Billion by 2020 from $1.09 Billion in 2015, growing at a CAGR of 8.2% from 2015 to 2020.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) – Forecast to 2017
The market is broadly classified into two segments, namely, diagnostic and therapeutic; the former dominated with about 80.7% share in 2012. Radioisotopes in the diagnostic market are categorized as SPECT and PET. Technetium 99m (Tc-99m) dominated the SPECT radioisotope market in 2012, followed by thallium–201(Tl-201), gallium–67 (Ga-67), and iodine-123 (I-123). SPECT is majorly used in cardiology-related diagnosis; it is poised to grow at a CAGR of 10.2% from 2012 to 2017. The radiopharmaceuticals market in the Asia-Pacific region was valued at $500.8 million in 2012; it is poised to reach $824.9million in 2017 at a CAGR of 10.5%.
- Published: May 2013
- Price: $ 4950
- TOC Available:
-
Preclinical Imaging Market by Product (Optical Imaging (Bioluminescence), Nuclear Imaging (PET, SPECT), MRI, Reagents (Luciferins, Infrared Dyes), Software), Application (Onco, Cardio), End User (Pharma, Biotech, Academic, CRO) - Global Forecast to 2030
The global preclinical imaging market, valued at US$3.36 billion in 2024, stood at US$3.53 billion in 2025 and is projected to advance at a resilient CAGR of 4.5% from 2024 to 2030, culminating in a forecasted valuation of US$4.39 billion by the end of the period.
- Published: December 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
